(LANC) Lancaster Colony - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US5138471033
LANC: Frozen Bread, Salad Dressings, Dips, Croutons, Pasta Sauces
Lancaster Colony Corporation, trading under NASDAQ:LANC, is a notable player in the specialty food sector, focusing on manufacturing and marketing for both retail and foodservice channels. Their operations are divided into two segments: Retail and Foodservice, which together form a robust structure for their market approach.
The company boasts a diverse portfolio of products, including frozen garlic bread under the New York BRAND Bakery label and Parkerhouse rolls under Sister Schuberts. Their salad dressings are marketed through several brands: Marzetti, Cardinis, Simply Dressed, and Girards. Additionally, they offer vegetable and fruit dips under Marzetti, and croutons and toppings through New York BRAND Bakery, Chatham Village, and Marzetti. Their frozen pasta line also falls under the Marzetti brand, showcasing their comprehensive range in the frozen food category.
Beyond their own brands, Lancaster Colony leverages strategic partnerships, manufacturing products for well-known restaurants such as Olive Garden, Buffalo Wild Wings, and Chick-fil-A. This diversification not only enhances their revenue streams but also underscores their reliability as a supplier. Their distribution network includes direct sales personnel, food brokers, and distributors, ensuring wide market penetration across retailers and restaurants.
Financially, Lancaster Colony presents a market cap of $5.2 billion, with a trailing P/E of 32.99 and a forward P/E of 36.50, indicating investor confidence in their growth prospects. Their price-to-book ratio of 5.28 and price-to-sales of 2.77 highlight a premium valuation, reflecting their strong market position and brand equity in the packaged foods sector. Established in 1961 and headquartered in Westerville, Ohio, the companys longevity and consistent performance position it as a stable entity in a competitive industry.
Additional Sources for LANC Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
LANC Stock Overview
Market Cap in USD | 4,987m |
Sector | Consumer Defensive |
Industry | Packaged Foods |
GiC Sub-Industry | Packaged Foods & Meats |
IPO / Inception | 1990-03-26 |
LANC Stock Ratings
Growth 5y | 27.0% |
Fundamental | 52.0% |
Dividend | 59.8% |
Rel. Strength Industry | -15.2 |
Analysts | 3.29/5 |
Fair Price Momentum | 172.86 USD |
Fair Price DCF | 146.83 USD |
LANC Dividends
Dividend Yield 12m | 2.03% |
Yield on Cost 5y | 3.01% |
Annual Growth 5y | 5.07% |
Payout Consistency | 94.8% |
LANC Growth Ratios
Growth Correlation 3m | 33.2% |
Growth Correlation 12m | -34.3% |
Growth Correlation 5y | 59.2% |
CAGR 5y | 7.92% |
CAGR/Max DD 5y | 0.20 |
Sharpe Ratio 12m | -0.08 |
Alpha | -16.39 |
Beta | 0.61 |
Volatility | 27.67% |
Current Volume | 90.9k |
Average Volume 20d | 142.1k |
As of March 16, 2025, the stock is trading at USD 180.02 with a total of 90,917 shares traded.
Over the past week, the price has changed by -6.48%, over one month by -4.09%, over three months by -6.42% and over the past year by -8.24%.
Partly, yes. Based on ValueRay Fundamental Analyses, Lancaster Colony (NASDAQ:LANC) is currently (March 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 51.97 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of LANC as of March 2025 is 172.86. This means that LANC is currently overvalued and has a potential downside of -3.98%.
Lancaster Colony has received a consensus analysts rating of 3.29. Therefor, it is recommend to hold LANC.
- Strong Buy: 1
- Buy: 0
- Hold: 6
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, LANC Lancaster Colony will be worth about 189.3 in March 2026. The stock is currently trading at 180.02. This means that the stock has a potential upside of +5.15%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 205.2 | 14% |
Analysts Target Price | 197.6 | 9.8% |
ValueRay Target Price | 189.3 | 5.2% |